R. Castillo

发表

NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against β-Lactamase-Producing Strains

G. Wahl, H. Shepard, M. Hixon, 2002, Antimicrobial Agents and Chemotherapy.

The design, synthesis, and evaluation of two universal doxorubicin-linkers: preparation of conjugates that retain topoisomerase II activity.

A. Castellino, C. Ballatore, Amos B. Smith, 2006, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of N2-aryl-3-(isoxazolylsulfamoyl)-2-thiophenecarboxamides as selective endothelin receptor-A antagonists.

I. Okun, M. Chan, R. Castillo, 1997, Journal of medicinal chemistry.

Mechanism of Action of NB2001 and NB2030, Novel Antibacterial Agents Activated by β-Lactamases

N. Georgopapadakou, M. Sergeeva, V. Doppalapudi, 2004, Antimicrobial Agents and Chemotherapy.

Mechanism of Action of NB2001 and NB2030, Novel Antibacterial Agents Activated by (cid:2) -Lactamases

N. Georgopapadakou, M. Sergeeva, V. Doppalapudi, 2004 .

Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists.

C. Larive, V. N. Balaji, M. Chan, 2009 .

The discovery and structure—activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor

I. Okun, E. Verner, V. N. Balaji, 1998 .

Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells.

M. J. Newman, Zijian Guo, A. Castellino, 2006, Bioorganic & medicinal chemistry letters.

2-Aryloxycarbonylthiophene-3-sulfonamides: Highly potent and etA selective endothelin receptor antagonists

I. Okun, M. Chan, R. Castillo, 1997 .

Halogen substitution at the isoxazole ring enhances the activity of N-(isoxazolyl)sulfonamide endothelin antagonists

I. Okun, E. Verner, V. N. Balaji, 1996 .